JP Morgan Chase’s Centogene N.V. Common Shares CNTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13
Closed -$5 7805
2024
Q2
$5 Hold
13
﹤0.01% 7250
2024
Q1
$10 Hold
13
﹤0.01% 7236
2023
Q4
$16 Hold
13
﹤0.01% 7385
2023
Q3
$15 Hold
13
﹤0.01% 7238
2023
Q2
$20 Sell
13
-858
-99% -$726 ﹤0.01% 6789
2023
Q1
$1K Hold
871
﹤0.01% 6578
2022
Q4
$1K Buy
871
+332
+62% +$302 ﹤0.01% 6467
2022
Q3
$1K Buy
539
+526
+4,046% +$858 ﹤0.01% 6393
2022
Q2
$0 Sell
13
-232
-95% -$727 ﹤0.01% 6994
2022
Q1
$1K Sell
245
-7,044
-97% -$29.6K ﹤0.01% 6509
2021
Q4
$37K Buy
7,289
+6,642
+1,027% +$54.1K ﹤0.01% 6047
2021
Q3
$7K Buy
647
+613
+1,803% +$6.63K ﹤0.01% 6221
2021
Q2
$0 Sell
34
-22,962
-100% -$241K ﹤0.01% 6676
2021
Q1
$279K Buy
22,996
+1,151
+5% +$13.7K ﹤0.01% 5007
2020
Q4
$236K Buy
21,845
+15,758
+259% +$180K ﹤0.01% 4755
2020
Q3
$58K Buy
6,087
+3,102
+104% +$39.5K ﹤0.01% 4904
2020
Q2
$68K Sell
2,985
-69
-2% -$1.29K ﹤0.01% 4720
2020
Q1
$61K Buy
3,054
+586
+24% +$8.12K ﹤0.01% 4679
2019
Q4
$25K Buy
+2,468
New +$29.4K ﹤0.01% 5286

Other funds holding CNTG

JP Morgan Chase's CNTG Position: Q3 2024 in Review

JP Morgan Chase sold out of Centogene N.V. Common Shares (CNTG) in Q3 2024, closing a stake of 13 shares — an estimated $5 sold.

JP Morgan Chase first reported a position in CNTG in Q4 2019 and held it in 19 quarters. The position peaked at $279K in Q1 2021. 1 fund tracked by Wall St. Rank holds CNTG as of Q3 2024.

  • JP Morgan Chase reported no remaining Centogene N.V. Common Shares position as of Q3 2024 after selling out during the quarter.
  • JP Morgan Chase sold 13 Centogene N.V. Common Shares shares in Q3 2024, an estimated $5.
  • JP Morgan Chase first reported a position in Centogene N.V. Common Shares in Q4 2019 and held it in 19 quarters.
  • JP Morgan Chase's Centogene N.V. Common Shares position peaked at $279K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Centogene N.V. Common Shares as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.